What are the next steps for a patient with normal tissue transglutaminase (tTG) Immunoglobulin G (IgG) and low Immunoglobulin A (IgA) levels, suspected of having celiac disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnostic Approach for Low IgA with Normal tTG IgG

Immediate Next Step

Order IgG-based celiac serology immediately, specifically IgG deamidated gliadin peptide (DGP-IgG), as low IgA levels render standard IgA-based celiac testing unreliable and may mask celiac disease. 1

Confirm IgA Deficiency

  • Verify the total IgA level is truly deficient (typically <7 mg/dL or below age-specific reference ranges) to confirm that IgA-based testing is invalid 1, 2
  • IgA deficiency occurs 10-15 times more frequently in celiac disease patients compared to healthy controls, affecting 1.7% of celiac patients 3, 4, 5
  • The normal tTG IgG result is not reassuring in this context, as tTG IgG has poor diagnostic accuracy (sensitivity only 40.6-84.6%, specificity 78.0-89.0%) and should not be used to exclude celiac disease 1

Preferred IgG-Based Testing

  • IgG deamidated gliadin peptide (DGP-IgG) is the preferred test in IgA-deficient patients, with superior diagnostic accuracy (93.6% sensitivity, 99.4% specificity) compared to tTG IgG 1, 6
  • If DGP-IgG is positive, proceed directly to upper endoscopy with duodenal biopsy to confirm diagnosis 1
  • Ensure the patient is consuming adequate gluten (at least 10g daily) at the time of testing and biopsy to avoid false-negative results 1, 7

Biopsy Protocol if IgG Testing is Positive

  • Obtain at least 6 biopsy specimens: 1-2 from the duodenal bulb and at least 4 from the second part of the duodenum or beyond 1, 7
  • Request evaluation by an experienced gastrointestinal pathologist to confirm proper tissue orientation and assess for villous atrophy 3, 7
  • If IgG-based serology is positive and villous atrophy is present, diagnose as selective IgA deficiency associated with celiac disease, not seronegative celiac disease 3

Additional Considerations

  • Consider HLA-DQ2/DQ8 genetic testing if clinical suspicion remains high despite negative IgG serology, as absence of both alleles has >99% negative predictive value and effectively rules out celiac disease 3, 7
  • If IgG and IgM levels are also low (not just IgA), refer to immunology for evaluation of common variable immunodeficiency, which can also cause villous atrophy 3, 5
  • Screen for other autoimmune conditions commonly associated with IgA deficiency and celiac disease, including type 1 diabetes and autoimmune thyroid disease 6, 7

Monitoring After Diagnosis

  • Use the same IgG-based antibody tests (DGP-IgG or tTG-IgG) for monitoring dietary compliance and disease activity at 6 months, 12 months, and annually thereafter 1
  • Never rely on IgA-based testing for monitoring in patients with confirmed IgA deficiency 1

Critical Pitfall to Avoid

Do not exclude celiac disease based on normal tTG IgG alone in an IgA-deficient patient—this is a common diagnostic error that leads to missed celiac disease diagnoses. The tTG IgG has inadequate sensitivity and specificity for this purpose, and DGP-IgG must be ordered instead 1, 6

References

Guideline

Diagnostic Approach for Celiac Disease with Low IgA Levels

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Oral manifestations of selective IgA-deficiency: review and case-report.

Journal of biological regulators and homeostatic agents, 2017

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Celiac disease and selective immunoglobulin A deficiency.

The Journal of pediatrics, 1997

Guideline

Evaluating Discordant Celiac Disease Test Results

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Celiac Disease with Positive IgA but Negative Anti-TTG

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.